AETERNUM HEALTH, INC.

Aeternum Health, Inc. has acquired 100% of American Renaissance Minerals LLC (ARM), the entity advancing the Nkamouna Nickel-Cobalt mining project in Cameroon. The acquisition involves issuing up to 133,333,333 pre-split shares or pre-funded warrants to American Renaissance Resources LLC (ARR). ARR will receive observer rights to Aeternum's Board meetings under certain conditions. This move consolidates a previous option agreement into direct ownership, simplifying project advancement as ARM works with the Cameroonian government towards a new mining permit.

Aeternum Health, Inc. announced it has acquired an option from Manaslu LLC to purchase a 50.1% stake in American Renaissance Materials LLC. This acquisition marks Aeternum's entry into the mining and production of critical minerals, specifically targeting the Nkamouna Nickel-Cobalt mining project in Cameroon. The consideration for the option involved issuing 50,000,000 shares of common stock and 2,000,000 shares of Series B preferred stock. The Nkamouna project is highlighted as strategically important for the United States' critical mineral supply chains.

Aeternum Health, Inc., formerly Shorepower Technologies, Inc., announced the completion of its merger with Aeternum Health LLC on June 30, 2026. As part of the merger, the company changed its name and trading symbol to AETN, appointed Paul Mann as the new President/CEO and sole director, and issued 49,000,000 common shares and 2,000,000 Series B preferred shares to Mr. Mann. The company will now focus on critical mineral mining and developing longevity and optimal health solutions, spinning out its previous transportation electrification assets. Authorized shares were increased to 250 million to support the new business plan.

Aeternum Health, Inc. (formerly Shorepower Technologies Inc.) is undergoing a reverse merger with Aeternum Health LLC, pivoting its business from transportation electrification to healthcare, specifically longevity and anti-aging solutions. Paul Mann will become the new CEO, and Aeternum Health LLC will contribute intellectual property, data, and at least $1.5 million in cash. For Q1 2026, the company reported a significant revenue decline to $2,260 and a net loss of $139,655, alongside a going concern warning.